Cargando…

A Study on the Expression of BCR-ABL Transcript in Mixed Phenotype Acute Leukemia (MPAL) Cases Using the Reverse Transcriptase Polymerase Reaction Assay (RT-PCR) and its Correlation with Hematological Remission Status Post Initial Induction Therapy

INTRODUCTION: The MPAL comprise 2–5% of all acute leukemia. The present WHO 2008 classification has separated two groups in MPAL based on t(9;22) positivity and MLL rearrangement. AIMS & OBJECTIVES: The aim of the present pilot study is to note the frequency of BCR-ABL transcript in MPAL cases u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatia, Prateek, Binota, Jogeshwar, Varma, Neelam, Bansal, Deepak, Trehan, Amita, Marwaha, Ram Kumar, Malhotra, Pankaj, Varma, Subhash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375663/ https://www.ncbi.nlm.nih.gov/pubmed/22708039 http://dx.doi.org/10.4084/MJHID.2012.024

Ejemplares similares

Incidence of Common Fusion Transcripts in Adult and Pediatric Acute Myeloid Leukemia (AML) Cases: Experience of a Tertiary Care Research institute
por: Bhatia, Prateek, et al.
Publicado: (2012)

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia
por: Naseem, Shano, et al.
Publicado: (2021)

Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients
por: Gupta, Dikshat Gopal, et al.
Publicado: (2022)

A Case Series Highlighting the Relative Frequencies of the Common, Uncommon and Atypical/Unusual Hematological Findings on Bone Marrow Examination in Cases of Visceral Leishmaniasis
por: Bhatia, Prateek, et al.
Publicado: (2011)

Parvovirus B19 Infection in Pediatric Patients with Hematological Disorders
por: Singhal, Lipika, et al.
Publicado: (2013)

The Spectrum of Hypereosinophilia and Associated Clonal Disorders – A Real-World Data Based on Combined Retrospective and Prospective Analysis from a Tropical Setting
por: Sreedharanunni, Sreejesh, et al.
Publicado: (2018)

A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh
por: Malhotra, Pankaj, et al.
Publicado: (2013)

Haematological profile of patients with mixed-phenotype acute leukaemia from a tertiary care centre of north India
por: Sharma, Manupriya, et al.
Publicado: (2017)

The Accelerated Phase of Chediak-Higashi Syndrome: The Importance of Hematological Evaluation
por: Bharti, Shreekant, et al.
Publicado: (2013)

Mixed-phenotype acute leukemia (MPAL) and beyond
por: Kim, Hee-Je
Publicado: (2016)

Detection of NUP214-ABL1 translocation using BCR-ABL1 dual color FISH probes in T-cell acute lymphoblastic leukemia–an illustrative report and review of literature
por: Virk, Harpreet, et al.
Publicado: (2022)

Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: A single center experience
por: Bommannan, KB, et al.
Publicado: (2022)

Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India
por: Anand, Maninder Singh, et al.
Publicado: (2012)

Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
por: Serpa, Mariana, et al.
Publicado: (2010)

Treatment-Free Remission in Chronic Myeloid Leukemia Harboring Atypical BCR-ABL1 Transcripts
por: Dragani, Matteo, et al.
Publicado: (2020)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Low Expression of Leucocyte Associated Immunoglobulin Like Receptor-1 (LAIR-1/CD305) in a Cohort of Pediatric Acute Lymphoblastic Leukemia Cases
por: Singh, Minu, et al.
Publicado: (2018)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

Systemic Mastocytosis in a Patient with BCR-ABL1-Positive Chronic Myeloid Leukemia in the Remission Phase
por: Fokoloros, Christos, et al.
Publicado: (2022)

SHP2 Is Required for BCR-ABL1-Induced Hematologic Neoplasia
por: Gu, Shengqing, et al.
Publicado: (2017)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA.
por: R, Chethan, et al.
Publicado: (2023)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
por: Kawakami, Shohei, et al.
Publicado: (2022)

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)
por: Coster, Lucie, et al.
Publicado: (2021)

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
por: Salmon, Matthew, et al.
Publicado: (2022)

Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET
por: Shibata, Yoshiyuki, et al.
Publicado: (2010)

A look inside the body of a BCR-ABL1−like acute lymphoblastic leukemia patient: the first case report highlighting the continued relevance of autopsy practice
por: Rastogi, Pulkit, et al.
Publicado: (2021)

BCR: a new target in resistance mediated by BCR/ABL-315I?
por: Haberbosch, Isabella, et al.
Publicado: (2016)

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins
por: You, Liangshun, et al.
Publicado: (2016)

A paradigm shift: lineage switch from T-ALL to B/myeloid MPAL
por: Rath, Asish, et al.
Publicado: (2021)

Unique characteristics of leukocyte volume, conductivity and scatter in chronic myeloid leukemia
por: Gaspar, Balan Louis, et al.
Publicado: (2019)

Expanding the Diversity of Allosteric Bcr-Abl Inhibitors
por: Deng, Xianming, et al.
Publicado: (2010)

An In-House Method for Molecular Monitoring of BCR-ABL
por: Sercan, Hakkı Ogün, et al.
Publicado: (2012)

Depression of oncogenecity by dephosphorylating and degrading BCR-ABL
por: Gao, Miao, et al.
Publicado: (2016)

Reverse Transcription Can Critically Impact the Diagnostic Outcome of BCR::ABL1 Quantitative Real-Time RT-PCR
por: Spiess, Birgit, et al.
Publicado: (2023)

Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia
por: Samanta, A, et al.
Publicado: (2011)

Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression
por: Srinivasan, Vishrut K., et al.
Publicado: (2020)

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
por: Zhou, Liang L., et al.
Publicado: (2008)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
por: Zeng, Dachuan, et al.
Publicado: (2022)

Shoulder pain: a hematologist’s perspective
por: Jain, Ankur, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9gk5p4mtnq51lhl1cim479ob87